Anglerfish, Gila Monsters, and the Origin of ...

Up next

Earnings, Earnings, and (You Guessed it) More Earnings

Earnings results are flooding in from companies across numerous industries Some look great, some look ok, and some the market didn’t like one bit. Today, we break down earnings results from several consumer companies to see spending trends, the gang gets into a spirited back and ... Show more

. 23min 21sec

Warren Buffett’s Last Hurrah

We got the final filing of Berkshire Hathaway’s stock holdings this week and it once again showed Warren Buffett selling tech stocks to buy consumer goods companies. Then we discussed Netflix’s latest saga buying Warner Bros. Discovery and why homebuilders are building fewer home ... Show more

. 19min 33sec

Recommended Episodes

The weight-loss drug revolution

Business Daily

Diabetes and obesity drugs like Ozempic, Wegovy and Mounjaro have become famous for helping users shed big amounts of weight. It's a market that could soon be worth more than $100 billion. Two companies dominate this space, Novo Nordisk which makes Ozempic and Eli Lilly, maker of ... Show more

. 17min 28sec

The Big Business Behind Weight Loss Drugs

Chasing Life

It’s become a multibillion-dollar business: weight loss drugs. Demand is high, as is the cost. How did medications like Ozempic, Wegovy, Mounjaro and Zepbound become so popular and so profitable? And what kind of impact might they have on the future of food and healthcare? Dr. Sa ... Show more

. 33min 54sec

113. Susan Peirce Thompson went from being addicted to drugs and alcohol to turning her life around, and building a multi-million dollar weight loss business.

Success Hackers | Empowering Entrepreneurs to Play Bigger in Business and Life

Susan Peirce Thompson is an entrepreneur, brain and cognitive scientist, and food psychologist. She's a Ph.D, and author of the new book Bright Line Eating: The Science of Living Happy, Thin, & Free. She built her business to over $6MM in revenue (with a 300k+ list) in under a ye ... Show more

. 30min 9sec

The Scientific Journey Behind Ozempic (with Lotte Bjerre Knudsen, Novo Nordisk's Chief Scientific Advisor)

ACQ2 by Acquired

On our Novo Nordisk episode, we covered the business of Ozempic, the GLP-1 taking the world by storm. On this episode, we dive into the science of the molecule semaglutide (and its predecessor liraglutide) with the world expert on the topic, Lotte Bjerre Knudsen. Lotte is Novo No ... Show more

. 1h 0min